Vaccinescontainingplant-derivedr HAeitherinsolubleformor
in virus-like particles (VLPs) have been shown to be safe and
immunogenic in humans34–37. A plant-derived recombinant
quadrivalent VLP (QVLP) at 30µg dose per strain was found to
be non-inferior in terms of vaccine efficacy against respiratory